Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Permata Tbk (BNLI) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Bank Permata TbkTrade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank Permata Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bank Permata Tbk trades at Rp2,330 (market cap 83.46T, 45.6K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Bank Permata Tbk is far larger — about 268.6× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 45.6K). Which is the better fit depends on your goals.

BNLIDGNS
Market Cap
83.46T310.75B
Volume
45.6K963.6K
Lot
4569.64K
Turnover
106.92M217.67M
Average Price
2,344.82225.89
Value
106.92M217.67M
Indicative Equilibrium Price
2,330226
Indicative Equilibrium Volume
311K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BNLI
View details
DGNS
View details

About Bank Permata Tbk

PT Bank Permata Tbk (formerly PT Bank Bali) was established in Indonesia on December 17, 1954, under the name of Bank Persatuan Dagang Indonesia, the bank changed to its present name in 1971. Bank Bali is Indonesia`s eighth largest private national. The majority of its clients are medium sized institutions.

Read more on BNLI

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS